PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases
author
statement of authorship
V.Z. Lankin, A.K. Tikhaze, M. Viigimaa, I.E. Chazova
source
Terapevticheskii Arkhiv
publisher
CJSC Consilium Medicum
journal volume number month
Vol. 90, 9
year of publication
pages
p. 27-30
subject term
keyword
ISSN
0040-3660
notes
Bibliogr.: 15 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
category (general)
category (sub)
kvartiil
TTÜ department
language
inglise
Lankin, V.Z., Tikhaze, A.K., Viigimaa, M., Chazova, I.Å. PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases // Terapevticheskii Arkhiv (2018) Vol. 90, 9, p. 27-30.